Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach.

about

The Implication of the Brain Insulin Receptor in Late Onset Alzheimer's Disease Dementia.The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease.

P2860

Q47831375-FB28157B-CB6E-4B62-A393-B299C884E288 Q50050282-14C67FD9-00B3-4978-B52B-3F5EC825A912

P2860

Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach.

Item

http://www.wikidata.org/entity/Q42748376

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Type 2 Diabetes, Cognition, an ...... d a Precision Health Approach.

@en

Type 2 Diabetes, Cognition, an ...... d a Precision Health Approach.

@nl

type

Item

label

Type 2 Diabetes, Cognition, an ...... d a Precision Health Approach.

@en

Type 2 Diabetes, Cognition, an ...... d a Precision Health Approach.

@nl

prefLabel

Type 2 Diabetes, Cognition, an ...... d a Precision Health Approach.

@en

Type 2 Diabetes, Cognition, an ...... d a Precision Health Approach.

@nl

P1476

Type 2 Diabetes, Cognition, an ...... d a Precision Health Approach.

@en

P2093

Brenna Cholerton

http://www.w3.org/2001/XMLSchema#string

Laura D Baker

http://www.w3.org/2001/XMLSchema#string

Suzanne Craft

http://www.w3.org/2001/XMLSchema#string

Thomas J Montine

http://www.w3.org/2001/XMLSchema#string

P2860

Diet and Alzheimer’s disease risk factors or prevention: the current evidence

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence

Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study

Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation

Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers

Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study

Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment.

A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease.

Brain imaging in type 2 diabetes.

P304

210-219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DS16-0041

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27899872

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

dementia

P932

5111529

http://www.w3.org/2001/XMLSchema#string

Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach.

about

P2860

P2860

Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932